Spada, F.; Rossi, R.E.; Kara, E.; Laffi, A.; Massironi, S.; Rubino, M.; Grimaldi, F.; Bhoori, S.; Fazio, N.
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals 2021, 14, 539.
https://doi.org/10.3390/ph14060539
AMA Style
Spada F, Rossi RE, Kara E, Laffi A, Massironi S, Rubino M, Grimaldi F, Bhoori S, Fazio N.
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals. 2021; 14(6):539.
https://doi.org/10.3390/ph14060539
Chicago/Turabian Style
Spada, Francesca, Roberta E. Rossi, Elda Kara, Alice Laffi, Sara Massironi, Manila Rubino, Franco Grimaldi, Sherrie Bhoori, and Nicola Fazio.
2021. "Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management" Pharmaceuticals 14, no. 6: 539.
https://doi.org/10.3390/ph14060539
APA Style
Spada, F., Rossi, R. E., Kara, E., Laffi, A., Massironi, S., Rubino, M., Grimaldi, F., Bhoori, S., & Fazio, N.
(2021). Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals, 14(6), 539.
https://doi.org/10.3390/ph14060539